Advisory Services Network’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $295K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $22.4K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $39.5K | Buy |
|
|||||
|
2022
Q4 | $37.2K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $77K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $42K | Hold |
|
|||||
|
2020
Q3 | $20K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $11K | Hold |
|
|||||
|
2019
Q4 | $20K | Buy |
|
|||||
|
2019
Q3 | $15K | Hold |
|
|||||
|
2019
Q2 | $15K | Hold |
|
|||||
|
2019
Q1 | $33K | Hold |
|
|||||
|
2018
Q4 | $32K | Sell |
|
|||||
|
2018
Q3 | $34K | Hold |
|
|||||
|
2018
Q2 | $26K | Sell |
|
|||||
|
2018
Q1 | $31K | Hold |
|
|||||
|
2017
Q4 | $32K | Hold |
|
|||||
|
2017
Q3 | $34K | Hold |
|
|||||
|
2017
Q2 | $36K | Hold |
|
|||||
|
2017
Q1 | $55K | Buy |
|
|||||
|
2016
Q3 | $31K | Sell |
|
|||||
|
2016
Q2 | $30K | Buy |
|
|||||
|
2016
Q1 | $17K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $106K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $394K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $59K | Buy |
|